Diagnostic and therapeutic approaches of mixed cryoglobulinemia in PITER (Piattaforma Italiana per lo studio della Terapia delle Epatiti viRali) cohort
Loreta A. Kondili(Istituto Superiore di Sanità), Anna Linda Zignego(University of Florence), Luisa Cavalletto(University of Padua), Massimo Puoti(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Marco Massari(Azienda Sanitaria Unità Locale di Reggio Emilia), Martina Quaranta, Carlotta Cerva(University of Rome Tor Vergata), S. Palladini, Guglielmo Borgia(University of Naples Federico II), Romina Corsini(Azienda Ospedaliera S.Maria), Mc Pasetto, G. Mazzella(University of Bologna), Luchino Chessa(University of Cagliari), Mario Masarone(University of Salerno), Seana Vella, Monica Monti(University of Florence), Genéviève Costa Freitas Lazzarini, Marcello Persico(University of Salerno), Avra Alberti, D. Ieluzzi, Marzia Margotti(University of Bologna), E Danieli, M. Vinci(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Nicola Passigato, L. Chemello(University of Padua), Emanuela Zappulo, M. Gonzo, Massimo Andreoni(University of Rome Tor Vergata), Valentina Sciola, Marcello Dallio(University of Campania "Luigi Vanvitelli"), Pietro Andreoné, B. Coco(Azienda Ospedaliera Universitaria Pisana), Maurizia Rossana Brunetto(University of Pisa), Elisa Biliotti(Sapienza University of Rome), Maria Grazia Rumi(University of Milan), Alessandro Federico(University of Campania "Luigi Vanvitelli"), G.B. Gaeta, Liliana Elena Weimer(Istituto Superiore di Sanità), S. Madonia, G. Taliani, Vincenzo Rizzo
Cited by 1
Related Papers
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
|The Lancet Rheumatology|2020|998
Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
|The Lancet. Gastroenterology & hepatology|2022|664
Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response.
|Journal of Clinical Investigation|1996|661